Table 1 Baseline information of Aspirin treated group and DAPT treated group
|  | Aspirin (n = 11) | DAPT (n = 17) | p |
|---|---|---|---|
Age, years (SD) | 56 (8) | 54 (8) | 0.494 |
Male, n (%) | 9 (82) | 15 (88) | 0.999 |
BMI (SD) | 26.9 (2.7) | 25.5 (4.3) | 0.345 |
Current smoking | 3 (27.3) | 2 (11.8) | 0.353 |
Current drinking | 2 (18.2) | 1 (5.9) | 0.543 |
T2DM, n (%) | 3 (27) | 6 (35) | 0.999 |
HTN, n (%) | 6 (52) | 11 (65) | 0.701 |
Drugs, n (%) | Â | Â | Â |
ACEI/ARB | 3 27) | 6 (35) | 0.999 |
β-blokers | 9 (82) | 12 (71) | 0.668 |
CCBs | 2 (18) | 5 (29) | 0.668 |
Nitrates | 5 (46) | 9 (53) | 0.999 |
HbA1c, % (SD) | 6.1 (0.9) | 6.2 (0.8) | 0.781 |
Glucose, mmol/l (SD) | 5.8 (1.3) | 6.3 (1.6) | 0.476 |
TC, mmol/l (SD) | 4.3 (0.9) | 3.6 (0.9) | 0.050 |
LDL, mmol/l (SD) | 2.6 (0.8) | 2.1 (0.7) | 0.149 |
HDL, mmol/l (SD) | 1.1 (0.4) | 1.1 (0.3) | 0.991 |
TG, mmol/l (SD) | 2.4 (1.1) | 1.3 (0.6) | 0.003 |
LVEF (%), SD | 63.6 (7.7) | 61.4 (5.8) | 0.407 |